Scientists from WuXi STA and our partner Kura Oncology published this OPR&D paper discussing a new process for commercial-scale production of Tipifarnib that dramatically reduced waste disposal and increased output by 60%.
Scientists from WuXi STA and our partner Kura Oncology published this OPR&D paper discussing a new process for commercial-scale production of Tipifarnib that dramatically reduced waste disposal and increased output by 60%.